Lifestyle -- June 29, 2026: Americans will soon have access to a new sunscreen ingredient for the first time in more than 25 years, marking an important step forward in sun protection.
The U.S. Food and Drug Administration (FDA) recently approved bemotrizinol (BEMT) as a new active ingredient for over-the-counter sunscreens. The ingredient has been used safely in Europe and many other countries for decades and is recognized for providing strong protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays.
According to the FDA, bemotrizinol has low absorption through the skin and has been determined to be generally recognized as safe and effective (GRASE) for adults and children 6 months of age and older.
Why This Matters
Sun exposure remains one of the leading preventable causes of skin cancer, premature skin aging, and sunburn. Dermatologists recommend using a broad-spectrum sunscreen every day, even on cloudy days, because ultraviolet rays can penetrate clouds and reach the skin year-round.
The American Academy of Dermatology recommends using a sunscreen that:
Is broad-spectrum, protecting against both UVA and UVB rays.
Has an SPF of at least 30.
Is water resistant when participating in outdoor activities.
Experts also recommend reapplying sunscreen every two hours, or more frequently after swimming or heavy sweating.
What Makes Bemotrizinol Different?
Bemotrizinol is known for several advantages:
Provides broad-spectrum UVA and UVB protection.
Remains stable in sunlight, allowing it to continue protecting the skin during sun exposure.
Has very low absorption into the body.
Can be formulated into lightweight lotions, creams, and sprays without leaving the white residue often associated with some mineral sunscreens.
Many dermatologists believe the addition of bemotrizinol will give consumers more choices and may encourage more people to wear sunscreen consistently.
When Will It Be Available?
Although the FDA approval is now final, consumers should not expect to find products containing bemotrizinol immediately.
The FDA's final order becomes effective August 9, 2026, allowing manufacturers to begin marketing sunscreens containing the new ingredient. Some products are expected to begin appearing in stores in late summer or early fall, while wider availability is likely to continue expanding into 2027 as manufacturers introduce new formulations. Initially, the ingredient will be marketed under the trade name Parsol® Shield.
Sun Protection Still Matters
Whether using a traditional sunscreen or one containing the new ingredient, health experts emphasize that sunscreen is only one part of protecting your skin.
Additional recommendations include:
Wear a wide-brimmed hat and UV-blocking sunglasses.
Seek shade during the strongest sunlight hours, typically between 10 a.m. and 4 p.m.
Wear lightweight, long-sleeved clothing when spending extended time outdoors.
Perform regular skin self-examinations and consult a healthcare provider if you notice any changing moles or unusual skin lesions.
The approval of bemotrizinol gives consumers another safe and effective option for protecting their skin. As more products become available in the coming months, shoppers will have additional choices for daily sun protection while continuing one of the most effective ways to reduce the risk of skin damage and skin cancer.